Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Nov 11, 2020 9:10 am EST

OPKO Health to Participate in Three Upcoming Investment Conferences

Oct 29, 2020 4:05 pm EDT

OPKO Health Reports 2020 Third Quarter Business Highlights and Financial Results

Oct 20, 2020 8:00 am EDT

OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test

Oct 13, 2020 12:51 pm EDT

OPKO Health to Report Third Quarter 2020 Financial Results on October 29, 2020

Oct 9, 2020 8:00 am EDT

OPKO Health's BioReference Laboratories Launches COVID-19 Testing Program for New York City Schools

Oct 8, 2020 11:38 am EDT

Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency

Sep 15, 2020 7:00 am EDT

OPKO Health Initiates Clinical Trial of RAYALDEE in COVID-19 Patients

Sep 2, 2020 4:05 pm EDT

OPKO Health to Participate in Two September Investment Conferences

Sep 2, 2020 8:00 am EDT

OPKO Health's BioReference Laboratories Announces New York City Schools COVID-19 Testing Program

Sep 1, 2020 3:55 pm EDT

OPKO Health's BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay